Less Is More: Low-Dose Direct Oral Anticoagulants for Extended Venous Thromboembolism Prophylaxis in Higher-Risk Patients

GATA Lot to Learn: Decoding the Drivers of Down Syndrome-Associated Acute Leukemias

More Than Medicine: Peer Connection as a Therapeutic Adjunct in Acute Leukemia

Pomalidomide: A Step on the PATH Forward for Treatment of Hereditary Hemorrhagic Telangiectasia

Dual BCR::ABL1 Inhibition Shows Promise in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

When to STOP Treatment for Immune Thrombocytopenia in Patients Experiencing a Complete Response on Thrombopoietin Receptor Agonists

No Scientific Link Found Between Sickle Cell Trait and Sudden Death

Does This Star ‘GLO’? Taking Aim at Second-Line Diffuse Large B-Cell Lymphoma With Glofitamab Plus Gemcitabine and Oxaliplatin

The Rise of the HLA-Mismatched Unrelated Donor Transplant in the U.S.

The End of Transplant for Mantle Cell Lymphoma

DREAMMing of a Better Tomorrow: Belantamab-Based Triplet Therapy for Relapsed/Refractory Multiple Myeloma

Haploidentical Stem Cell Transplantation Is an Acceptable Transformative Therapy for Young Adults With Sickle Cell Disease

Enhancing Risk Stratification for Pediatric B-Cell Acute Lymphoblastic Leukemia: No Longer a ‘PI’ in the Sky Idea?

A Leap of Faith? Elimination of Autologous Stem Cell Transplantation for Patients With Mantle Cell Lymphoma in First Remission

Anticoagulation Stewardship

Blood Global Hematology Editor-in-Chief Shares Vision

One on One With Dr. Fred Appelbaum

Genetic Switch System Suggests Targeting of Mutant JAK2 Reverses Myeloproliferative Neoplasms

Venous Thromboembolism Risk Markers and Discontinuing Combined Hormonal Contraceptives

Growing the Next Generation of Hematologists